PHIL Philogen S.p.A.

22.25EUR0.00%Mkt Cap: 972.98M $P/E: 3.99

Philogen S.p.A., a biotechnology company, engages in the research and development of drugs for oncology and chronic inflammatory diseases in Italy, Switzerland, the United States, and the European Union. The company deve…

HeadlineSourceTime
This week
MarketScreener Italia
Older
la Repubblica
la Repubblica
la Repubblica
Borsa Italiana
MarketScreener Italia
MarketScreener Italia
Investing.com
MarketScreener Italia
SoldiOnline.it
la Repubblica
Borsa Italiana
MarketScreener Italia
MarketScreener Italia
MarketScreener Italia
MarketScreener Italia
Borsa Italiana
Borsa Italiana
SoldiOnline.it
la Repubblica
TradingView
QQuotazioni, Borsa, Economia e Finanza